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Abstract
The venom of Echis multisquamatus (Central Asian
sand viper) contains a single prothrombin activator,
designated multisquamase, which is structurally and
functionally different from ecarin, the prothrombin
activator from the venom of Echis carinatus (saw-
scaled viper). Multisquamase is comprised of a
58000 Mr and a 23000 Mr subunit that consists of
two disulfide-linked chains of 12000 Mr and 10000
Mr, respectively. In contrast to ecarin, which acti-
vates prothrombin and prethrombin 1 at compara-
ble rates, and whose activity is hardly affected by
Ca*+ or by changes in ionic strength, multisqua-
mase hardly activates prethrombin 1; prothrombin
activation requires Ca*+ and is strongly inhibited
at high ionic strength. The most favourable kinetic
parameters are observed at 1 mM Ca2+ and at low
ionic strength (Kc,=0.0S5  FM and k,,,=0.68  s-’ at
1~0.04). An increase in ionic strength consider-
ably reduces the rate of prothrombin activation,
due to an increase of the K, (K,=0.8 FM and
kcat=1.03  s-l at 1~0.2). Studies in plasmas from
patients on oral anticoagulant therapy show that
Abbreviations: PPACK, phenylalanyl-prolyl-arginine chloromethyl
ketone; BCA, bicinchoninic acid; FPLC, fast protein liquid chro-
matography; INR, international normalized ratio; USP, U.S. Phar-
macopoeia; BSA, bovine serum albumin.
Corresponding author: Dr. G. Tans, Dpt. Biochemistry, Maas-
tricht University, P. 0. Box 616,620O  MD Maastricht, The Nether-
lands. Fax: 31-43-3670988;  E-mail: <g.tans@bioch.unimaas.nl>.
E. Multisquamatus venom only activates carboxyl-
ated prothrombin, whereas E. carinatus activates
both prothrombin and descarboxyprothrombin.
Thus, multisquamase-dependent prothrombin acti-
vation appears to require post-translational modifi-
cation of the gla-domain. This venom prothrombin
activator may, therefore, become a useful tool to
quantitate prothrombin and descarboxyprothrom-
bin in cases where vitamin K-dependent carboxyla-
tion of prothrombin is impaired. 0 1998 Elsevier
Science Ltd.
Key Words: Snake venom; Prothrombin activation; Echis
multisquamatus; Echis carinatus
T hrombin formation, one of the central reac-tions of blood coagulation, is the result oflimited proteolysis of the zymogen pro-
thrombin by blood coagulation factor Xa. Under
physiological conditions, prothrombin activation is
stimulated in a multiplicative way by the accessory
components: Ca2+, negatively charged phospholip-
ids and the protein cofactor, factor Va which to-
gether with factor Xa assemble in the so-called
prothrombinase complex.
Prothrombin can also be activated by proteases
present in snake venoms [l] from, amongst others,
Australian Elapidae, Crotalidae, Viperidae, and
Colubridae. Compared with factor Xa, venom acti-
vators can exhibit different mechanisms of pro-
thrombin activation and requirements for cofac-
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tom.  A well characterized and widely used pro-
thrombin activator is ecarin [2,3], the metallo-
protease present in Echis carinatus venom, that
converts prothrombin exclusively into meizo-
thrombin [4,5]. Ecarin not only activates prothrom-
bin, but also prethrombin 1 and the descarboxy
form of prothrombin [6-91.  Recently, Yamada et al.
published the characteristics of a second prothrom-
bin activator, callled  carinactivase, present in the
venom from Echis Carinatus, with properties differ-
ent from those reported for ecarin [7].
tion of thrombin with PPACK, the reaction mix-
ture was applied to a column (XK 5/10) with Q
Sepharose fast flow. Prethrombin 1 did not adhere
to the resin and fragment 1, and non-cleaved pro-
thrombin were eluted with a gradient of 250 to 600
mM NaCl. Human plasma, prothrombin, pre-
thrombin 1, fragment 1, and purified venom activa-
tors were stored at -80°C. Protein preparations
were homogeneous and ~95% pure as judged by
SDS-PAGE according to Laemmli [ll].
Here we report the purification and character-
ization of the prothrombin activator from the
venom of Echis multisquamatus.
1.2.1. Protein Concentrations
1. Materials and Methods
Protein concentrations were determined with the
micro BCA protein assay [12]. Prothrombin con-
centrations were determined after complete activa-
tion of prothrombin with Echis carinatus venom
as described earlier [13].
1.1. Materials 1.3. Methods
Hepes, Tris, EDTA, bovine serum albumin, and
ovalbumin were purchased from Sigma Chemical
Co. St. Louis, USA. The chromogenic substrates
S2238 and S2366 were supplied by Chromogenix,
Mdlndal, Sweden. Ecarin, the prothrombin activa-
tor from Echis carinatus venom was from Penta-
pharm, Basel, Switzerland. Crude Echis multisqua-
matus venom was from Latoxan, Rosans, France.
Heparin (USP activity 175 units/mg)  was from Leo
Pharmaceuticals, Weesp, The Netherlands. Micro
BCA protein assay kits were from Pierce, Rock-
ford, USA. Immobilon-P membranes were from
Millipore, Bedford MA 01730. Antibodies were
from Kordia, Leiden, The Netherlands and Sigma
Chemical Co. St. Louis, USA. Materials used for
protein purification and the FPLC-system were
from Pharmacia, Uppsala Sweden.
1.3.1. Prothrombin Activation
1.2. Proteins
Prothrombin activation was determined by mea-
suring the generation of amidolytic activity towards
chromogenic substrates (S2238 or S2366). Human
prothrombin or prethrombin 1 was preincubated
in a buffer containing 25 mM Hepes (pH 7.7) 175
mM NaCl at 37°C. When divalent  cations were
present, these were included in the preincubation
mixture. Activation was started by addition of ap-
propriate dilutions of crude venom or purified
venom activator in the same buffer. After different
time intervals samples were withdrawn from the
activation mixtures and transferred to cuvettes con-
taining a final volume of 1 ml of 50 mM Tris-HCl
(pH 7.9) 175 mM NaCl, 20 mM EDTA, 0.5 mg/
ml ovalbumin, and 235 PM S2238 at 37°C and the
amidolytic activity was quantitated as described
earlier [14]. The amounts of activated prothrombin
were calculated from a calibration curve made with
known amounts of active site-titrated thrombin.
Normal human plasma was obtained by collecting
nine parts of blood from healthy volunteers in one
part of 0.13 M trisodium citrate (pH 7.8). The blood
was centrifuged twice for 15 minutes at 3,000Xg
at room temperature. Plasma from orally anticoag-
ulated patients was a kind gift of Dr. Hamulyak
(Dept. of Hematology, University Hospital, Maas-
tricht). Human prothrombin was purified from
fresh frozen plasma according to DiScipio  et al.
[lo].  Prethrombin 1 was purified from a reaction
mixture of human prothrombin with thrombin in
50 mM Tris (pH 7.9) 175 mM NaCl. After inhibi-
During purification, the activity of the venom
activator was routinely assayed for prothrombin
activation in reaction mixtures that contained 0.1
IJ,M prothrombin, 3 mM CaCl,, and appropriate
dilutions of the venom activator.
When plasma prothrombin was activated, the
plasma was diluted 2000-fold  in a buffer containing
25 mM Hepes (pH 7.7), 175 mM NaCl, 1 mM CaCl,
and preincubated at 37°C. Activation was started
by addition of appropriate dilutions of crude venom
in the same buffer. After different time intervals
the amount of prothrombin activated was quanti-
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tated by measuring the generation of amidolytic
activity towards S2366 on a SLT platereader set in
the dual wavelength mode at 405492  nm. Since
crude Echis multisquamatus venom shows a remark-
ably high amidolytic activity towards S2238, the
activation of plasma prothrombin was quantitated
with S2366 in these experiments.
1.3.2. Kinetic Analysis
Initial rates (v) of prothrombin or prethrombin 1
activation were determined at varying substrate con-
centrations (S) and the kinetic parameters K, and
Vmax were obtained by fitting the v vs. S curves to
the Michaelis-Menten  equation (V=VmaxS/(K,+
S) using nonlinear least squares regression analysis.
1.3.3. Gel Electrophoretic
and Immunoblot Techniques
Gel electrophoresis of the purified activator was
carried out in the presence of SDS on 13% slabgels
[ll] in a Miniprotean II cell from BioRad and the
gels were stained with Coomassie Brilliant Blue
R-250. Products of prothrombin proteolysis in
plasma were identified after SDS-PAGE on 10%
slab gels, electrophoretic transfer of proteins from
the gel to Immobilon-P membranes, and visualiza-
tion with a monoclonal  mouse-antibody directed
against human prothrombin and anti-mouse IgG
conjugated with alkaline phosphatase [15].
2. Results
2.1. Purification of the Prothrombin
Activator from Echis Multisquamatus
The prothrombin activator present in the crude
venom from Echis multisquamatus was purified by
ion-exchange chromatography on Resource Q and
Mono S at pH 7.5. The activator adhered to Re-
source Q and was eluted with a linear salt gradient
(Fig. la) resulting in a purification of about 5-fold
with a 76% yield (Table 1). Subsequent chromatog-
raphy on Mono Q (Fig. lb) resulted in a further
two-fold purification and a final overall yield of
13% (Table 1). SDS-PAGE on 13% slab gels (Fig.
2) showed that the purified activator contains two
protein bands of 58000 and 23000 Mr, respectively,
and that the 23000 band consisted of two polypetide
chains held together by disulfide bond(s) as judged
from the reduced sample (Fig. 2, lane 3). The acti-
vator eluted as a single symmetrical peak during
gel permeation chromatography of Superdex-200
at Mr=67000  (data not shown). Attempts to sepa-
rate the two protein bands by incubation with 0.8
M NaSCN invariably resulted in complete loss of
prothrombin converting activity. We conclude,
therefore, that the purified activator is a two subunit
enzyme. Furthermore, multisquamase likely is a
metalloproteinase since treatment with EDTA (O.l-
- -
0.6 - A
0 0 5 10 15
ELUTION  VOLUME (ml)
Fig. 1. Ion-exchange chromatography of the prothrombin activator from Echis multisquamatus. Panel A. 6 mg crude
venom was dissolved in 22 ml of 25 mM Hepes (pH 7.5) 50 mM NaCl, and 3 mM CaCl,, applied at a flow rate of 0.5
ml/min to a 1 ml Resource Q column and washed with 20 ml startbuffer. Bound protein was eluted with a linear gradient
of 2X5 ml (50 mM to 500 mM NaCl) in the same buffer. Protein was monitored by Azso (solid line) and fractions were
tested for prothrombin activation (B-m) as decribed  under “Material and Methods”. Panel B. Prothrombin activator-
containing fractions obtained after chromatography on Resource Q were pooled, diluted in 25 mM Hepes (pH 7.5), 3
mM CaCl, buffer to a final NaCl concentration of 50 mM, and applied to a 1 ml Mono S column. The activator was eluted
with a 2X5 ml linear gradient (50 mM to 500 mM NaCl) in 25 mM Hepes (pH 7.5) 3 mM CaCl,.
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Table 1. Purification of the prothrombin activator from Echis multi-
squamatus venom
Crude venom
Resource Q
Mono S
Specific Activity
Total Protein (nmol PT-activated/ Recovery
(mg) min/pg  venom) (%)
5.21 0.22 100
0.78 1.11 76
0.06 2.38 13
Protein was determined with the micro BCA assay [12]. Prothrombin activation was determined
as described under “Material and Methods.” PT=prothrombin.
0.3 mM)  resulted in a rapid loss of prothrombin
converting activity (data not shown). From the final
specific activity obtained it appears that an unusually
high percentage (-9%) of the crude venom actually
consists of prothrombin activator (Table 1).
2.2. Prothrombin and
Prethrombin 1 Activation
Rates of prothrombin and prethrombin 1 activa-
tion with purified activator were determined and
compared to those obtained with ecarin, the pro-
thrombin activator present in Echis carinatus
venom. It was verified that time courses of pro-
thrombin and prethrombin 1 activation were linear
with time and proportional to the amount of en-
zyme present (data not shown). Table 2 summa-
rizes the initial rates of activation of 1 FM pro-
thrombin or prethrombin 1 by 1 ng/ml  ecarin or
multisquamase. Prothrombin was activated some
threefold faster by ecarin than by multisquamase.
However, whereas ecarin activated prethrombin 1
and prothrombin at comparable rates, multisqua-
mase was almost unable to activate prethrombin
1 whose rate of activation was approximately 500-
fold slower than that of prothrombin (Table 2).
Figure 3 shows an experiment in which initial
rates of 0.1 PM prothrombin/prethrombin 1 activa-
tion by 4.5 ng/ml  ecarin or 10 ng/ml  multisquamase
were determined at varying NaCl concentrations.
Due to the fact that multisquamase-dependent pre-
thrombin 1 activation was extremely slow the latter
reaction was followed at a 50-fold  higher concentra-
tion (5 PM). At 30 mM NaCl, ecarin was a somewhat
better prothrombin activator than multisquamase
but, as can be seen, both prothrombin and prethrom-
bin 1 activation by multisquamase were strongly
inhibited at higher ionic strength. Furthermore, at
approximate physiological ionic strength, prothrom-
bin activation by multisquamase was some 50-100
fold faster than prethrombin 1 activation. In con-
strast, ecarin-catalyzed activation of prothrombin
or prethrombin 1 was much less affected by varia-
tion of the ionic strength and even at 400-500 mM
NaCl, prothrombin and prethrombin 1 activation
occurred at -40% of the rate observed at 30 mM
NaCl (Figure 3).
The kinetic parameters of prothrombin and pre-
thrombin 1 activation by ecarin and multisquamase,
1 2 3
Fig. 2. SDS-PAGE of crude venom (lane 1) and purified
activator (lanes 2-3) was carried out on 13% slab gels
according to Laemmli [ll].  5% B-mercaptoethanol  was
present in the reduced sample (lane 3). The gels were
stained with Coomassie Brilliant Blue R-250. Molecular
weights of reference markers are indicated.
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Table 2. Rate of prothrombin and prethrombin 1 activa-
tion by ecarin and multisquamase
Substrate
Prothrombin Prethrombin 1
Activator (nM activated/min/ng  activator)
Ecarin 1.52 1.01
Multisquamase 0.51 0.001
The initial rate of activation of 1 FM prothrombin or prethrombin 1 by 1 ngiml
ecarin or multisquamase was determined at 37°C in 25 mM Hepes (pH 7.7),
175 mM N&I,  5 mgiml BSA. and 1 mM CaCIx,  as described under “Materials
and Methods.”
determined at 30 mM NaCl(I=O.O4)  and at 175 mM
NaCl(I=O.2),  are summarized in Table 3. The Vmax
of prothrombin and prethrombin 1 activation were
minimally affected by an increase in the ionic
strength. The low rate of prethrombin 1 activation
by multisquamase is explained by its unfavourable
K, which is approximately 200-fold higher than the
K, for prothrombin. It appeared that the inhibition
observed for multisquamase at high ionic strength
was mainly due to an increase of the K,. The K,
for prethrombin 1 activation by multisquamase at
high ionic srength was increased so much that it
was impossible to obtain an accurate K, value
(Table 3). It appears, therefore, that the interaction
of multisquamase with prothrombin or prethrom-
bin 1 is driven (at least for a major part) by electro-
static interactions and for efficient interaction to
occur, the presence of fragment 1 is required.
However, prothrombin activation by multisqua-
mase appears to be also strongly dependent upon
the presence of Ca2+ as shown in Figure 4. Other
metal ions known to induce the conformational
change in prothrombin (Mg2+ or Mn2+ but not Ba2’)
[16]  also stimulated multisquamase-catalyzed pro-
thrombin activation (data not shown). In contrast,
ecarin-dependent prothrombin or prethrombin 1 ac-
tivation was hardly influenced by addition of di-
valent metal ions.
2.3. Activation of Prothrombin
and Descarboxyprothrombin
by Ecarin and Multisquamase
The above data strongly suggest that multisquamase
not only requires an intact but also a carboxylated
prothrombin molecule for efficient activation. To
test this, prothrombin present in normal plasma and
t-
k
I-
I 100 200 300 400 500
NaCl (mM)
Fig. 3. Initial rates of prothrombin and prethrombin 1 acti-
vation by ecarin and multisquamase at varying NaCl con-
centrations. The rate of activation of 0.1 PM prothrombin
(W, 0) and of 0.1 PM (A) or 5 ~.LM (A) prethrombin 1 by
4.5 ng/ml ecarin (B,A) or 10 ng/ml multisquamase @,A)
was determined as described under “Materials and Meth-
ods,” at 37°C in reaction mixtures containing 25 mM Hepes
(pH 7.7) 1 mM CaC12,  5 mg/ml BSA, and NaCl concentra-
tions as indicated in the figure.
in plasma from a patient treated with vitamin K
antagonists was activated with multisquamase. For
comparison the same plasma samples were also acti-
vated with ecarin (ecarin activates prothrombin, pre-
thrombin 1, and descarboxyprothrombin equally
well [6-91.  The immunoblot presented in Figure 5
shows that both activators converted all prothrom-
bin present in normal plasma and bands indicative
for meizothrombin-des-fragment 1 and (meizo)
thrombin-antithrombin III complexes became visi-
ble. In patient plasma, ecarin also activated all pro-
thrombin and descarboxyprothrombin, but with
multisquamase only part of the prothrombin present
was converted. This indicates that multisquamase
indeed only activated carboxylated prothrombin.
Thus, in principle the combination of prothrom-
bin activation with ecarin and multisquamase should
yield relevant information concerning the coagulant
status of prothrombin present in a given plasma
sample. Figure 6 shows the result of an experiment in
which the prothrombin and descarboxyprothrombin
present in a number of different plasma samples
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Table 3. Kinetic parameters of prothrombin and prethrombin 1 activation
30 mM NaCl 175 mM NaCl
V VOlPX
(h
(nmol azivated (nmol activated
min/pg act) (S min/pg act)
Ecarin
Prothrombin 0.05 2.55 0.15 1.43
Prethrombin 1 0.03 1.55 0.12 1.01
Multisquamase
Prothrombin 0.09 0.61 0.8 0.93
Prethrombin 1 22.92 1.11 >lOO n.d.
K, and V,,,  were obtained by fitting the Michaelis-Menten (v vs. S) curves using non-linear least squares regression
analysis. kcat was calculated assuming a Mr of 55000 for ecarin [6] and 67000 for multisquamase (see Results). Final
activation mixtures contained 25 mM Hepes (pH 7.7), 1 mM CaCl,,  5 @ml BSA, 30 or 175 mM N&I,  appropriate
dilutions of venom activators, and varying concentrations of prothrombin or prethrombin 1. n.d.=not  determined.
(randomly chosen from orally anticoagulated indi-
viduals, based on the INR values and independent
of medical background) was activated with crude
E. carinatus or with E. multisquamatus venom. Since
multisquamase is the only prothrombin activator
present in E. multisquamatus venom it is not neces-
sary to isolate multisqamase from the crude venom
for specific activation of prothrombin in a plasma
sample. To yield accurate measurement of pro-
3
E-
'E 2
z
'I
0
n I
0 2 8 10
Fig. 4. Effect of Ca2+ on prothrombin activation by ecarin
and multisquamase. Activation rates of 0.1 PM prothrom-
bin by 4.5 ng/ml ecarin (W) and 15 ng/ml multisquamase
(0) were determined as described under “Materials and
Methods”, at 37°C in 25mM Hepes (pH 7.7),  5 mg/ml BSA,
amounts of Ca*+ as indicated, and NaCl to yield a final
ionic strength of 0.2.
thrombin levels (without interference of endogen-
ous plasma inhibitors) the plasma samples were
diluted 2000-fold before activation. A good corre-
lation was observed when the ratio of the amidolytic
activity obtained with E. carinatus (prothrombin
plus descarboxyprothrombin) and with E. multi-
squamatus venom (prothrombin) was plotted
against the INR value.
3. Discussion
The venom from the viper Echis multisquamatus
contains a strong procoagulant which is capable of
activating prothrombin. This procoagulant, which
we call multisquamase, is a metalloproteinase that
consists of two subunits of 58000 and 23000 Mr. The
smaller subunit is comprised of two polypeptide
chains linked together via a disulfide bridge.
The structural and functional properties of the
E. multisquamatus activator are similar to those
of carinactivase, a second prothrombin activator
that was recently discovered to be present in the
venom from E. carinatus [7]. However, the catalytic
efficiency of multisquamase is not only dependent
on the presence of Ca*+ but is also strongly affected
by salt concentration. In addition, multisquamase
is the only enzyme with prothrombin-converting
activity present in the crude venom of E. multisqua-
matus. The fact that the crude venom did not acti-
vate prethrombin 1 at physiological ionic strength
is indicative for the absence of an ecarin-like pro-
thrombin activator in E. multisquamatus venom.
The catalytic efficiency of prothrombin activa-
-
R.J. Petrovan et al./Thrombosis Research 88 (1997) 309-316 315
98,000 -
64,000 -
50,000 -
36,000 -
30,000 -
Mf 1 2 3 4  5 6
- AT III-(T/MT)
- PT
- MTdesFl
Fig. 5. Immunoblot analysis of plasma prothrombin activation by ecarin and by the purified activator from E. multisquama-
tus. 40-fold dilutions of normal human plasma (lanes l-3) and plasma from a patient on oral anticoagulant therapy (lanes
4-6) in a buffer containing 25 mM Hepes (pH 7.7), 175 mM NaCl, 1 mM CaClz were activated with ecarin or multisquamase
to result in complete activation of prothrombin within 5 min. After the amidolytic activity reached a constant level, 16
~1 aliquots were subjected to SDS-PAGE (13% gel) according to Laemmli [ll].  Prothrombin and related products were
visualized after transblotting to immobilon membranes and immunologic staining as described under “Materials and
Methods.” The relative positions of reference molecular weight markers are indicated. Lane 1, normal plasma; lane 2,
normal plasma+ecarin; lane 3, normal plasma+multisquamase; lane 4, patient plasma; lane 5, patient plasma+ecarin; and
lane 6, patient plasma+multisquamase.
tion by multisquamase is rather high at low salt
concentrations (kcat/K,=8X 106) and similar to
that calculated for prothrombin and prethrombin
1 activation by ecarin at 175 mM NaCl. However,
at high salt concentrations the catalytic efficiency
of multisquamase is decreased, due to an increase
in the K, for prothrombin. Furthermore, K, for
prethrombin 1 is extremely high and in fact could
not be determined at physiological ionic strength
which explains the observation that under these
conditions multisquamase does not activate pre-
thrombin 1 at appreciable rates.
These data demonstrate the importance of the
fragment 1 region for efficient prothrombin activa-
tion by multisquamase. In addition divalent  cations
known to induce the conformational change in pro-
thrombin are required for efficient activation. Thus,
both crude E. multisquamatus venom and purified
activator do not activate prethrombin 1 at 175 mM
NaCl and require the presence of a carboxylated
fragment 1 region and the presence of Cazf for
efficient prothrombin activation.
In contrast, the kinetic parameters of prothrom-
bin or prethrombin 1 activation by ecarin are hardly
affected by the reaction conditions and the enzyme
does not show a similar requirement for the pres-
ence of Ca*+ and Gla residues.
The small pilot study, in which patient plasma
prothrombin levels were determined both with the
crude venoms from Echis carinatus and Echis
multisquamatus, shows that the combination of
these measurements correlated reasonably well
with the INR values obtained for the individual
plasma samples. These data indicate that Echis
multisquamatus venom may be of future use as a
tool to quantitate functional prothrombin in those
cases where vitamin K-dependent carboxylation of
prothrombin is hampered.
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the Dutch Organization for Scientific Research (NWO). R.J. Petro-
van was supported by the Deutscher Akademischer Austauschdienst
and Deutsche Akademie der Naturforscher “Leopoldina”.  We thank
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Fig. 6. Estimation of anticoagulation in plasma from orally
anticoagulated patients. Plasma samples (diluted l/2000)
were activated with crude E. carinatus and E. multisquama-
tus venom. Amidolytic activity present after 30 minutes
was determined using S2366 as a substrate, and the ratio of
amidolytic activities formed by E. carinatus and E. multi-
squamatus (EC/EM) is plotted vs. the INR values. The solid
line was obtained by linear regression analysis (R=0.83).
Further details are given under “Materials and Methods.”
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